SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 46.46

Change

-0.02 (-0.04)%

Market Cap

N/A

Volume

3.76M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+10.00 (+2.29%)

USD 128.84B
REGN Regeneron Pharmaceuticals Inc

+14.92 (+2.54%)

USD 65.38B
ARGX argenx NV ADR

-7.84 (-1.33%)

USD 34.54B
ALNY Alnylam Pharmaceuticals Inc

+0.14 (+0.05%)

USD 32.75B
ONC BeiGene, Ltd.

-3.12 (-1.29%)

USD 27.70B
SMMT Summit Therapeutics PLC

-0.21 (-0.81%)

USD 27.07B
RPRX Royalty Pharma Plc

+0.24 (+0.74%)

USD 18.40B
INSM Insmed Inc

+0.49 (+0.73%)

USD 11.84B
INCY Incyte Corporation

+1.11 (+1.72%)

USD 11.42B
BMRN Biomarin Pharmaceutical Inc

+0.56 (+0.97%)

USD 11.29B

ETFs Containing SWTX

SAFE:CA Global X Equal Weight Can.. 27.62 % 0.00 %

+0.36 (+-0.06%)

CAD 2.65M
FLI:CA CI U.S. & Canada Lifeco C.. 12.22 % 0.92 %

+0.21 (+-0.06%)

CAD 0.09B
HFIN:CA Hamilton Enhanced Canadia.. 11.55 % 0.00 %

+0.22 (+-0.06%)

CAD 0.19B
CEW:CA iShares Equal Weight Banc.. 9.77 % 0.60 %

+0.20 (+-0.06%)

CAD 0.23B
HFN:CA Hamilton Canadian Financi.. 9.51 % 0.00 %

-0.01 (-0.06%)

CAD 0.01B
HEF:CA 7.65 % 0.83 %

N/A

N/A
IDNA iShares Genomics Immunolo.. 5.18 % 0.00 %

+0.12 (+-0.06%)

USD 0.10B
XDNA:CA iShares Genomics Immunolo.. 4.82 % 0.00 %

+0.15 (+-0.06%)

CAD 4.62M
HLIF:CA Harvest Canadian Equity I.. 3.47 % 0.00 %

+0.07 (+-0.06%)

CAD 0.12B
HAL:CA Global X Active Canadian .. 3.42 % 0.78 %

+0.15 (+-0.06%)

CAD 0.12B
XMV:CA iShares MSCI Canada Minim.. 3.09 % 0.33 %

+0.43 (+-0.06%)

CAD 0.29B
CDEF:CA Manulife Smart Defensive .. 3.00 % 0.00 %

+0.18 (+-0.06%)

CAD 1.45M
XMD:CA iShares S&P/TSX Completio.. 2.16 % 0.61 %

+0.04 (+-0.06%)

CAD 0.28B
HPR:CA Global X Active Preferred.. 2.11 % 0.63 %

+0.02 (+-0.06%)

CAD 0.95B
BBP Virtus LifeSci Biotech Pr.. 0.00 % 0.79 %

+0.20 (+-0.06%)

USD 0.02B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FIE:CA iShares Canadian Financia.. 0.00 % 0.97 %

+0.07 (+-0.06%)

CAD 1.06B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

-0.10 (-0.06%)

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

+0.22 (+-0.06%)

N/A
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

+0.09 (+-0.06%)

CAD 0.40B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

N/A

N/A
CDIV:CA Manulife Smart Dividend E.. 0.00 % 0.00 %

+0.15 (+-0.06%)

CAD 0.64B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.59% 88% B+ 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.59% 88% B+ 89% A-
Trailing 12 Months  
Capital Gain 9.81% 78% C+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.81% 78% C+ 66% D+
Trailing 5 Years  
Capital Gain 26.08% 82% B 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.08% 82% B 51% F
Average Annual (5 Year Horizon)  
Capital Gain 3.39% 57% F 54% F
Dividend Return 3.39% 57% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 49.65% 63% D 36% F
Risk Adjusted Return 6.83% 60% D- 44% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector